Equitiesbullish4 min read
Eli Lilly ($LLY) Acquires Vaccine Developers in $3.8B Strategic Deal
Eli Lilly ($LLY) completes a $3.8 billion acquisition of vaccine development companies, strategically expanding its portfolio and market presence in the pharmaceutical sector.